Empliciti: HCP and Patient Campaigns

For Bristol Myers Squibb’s Empliciti (elotuzumab), approved for treating multiple myeloma in patients with one to three prior therapies, The Bloc developed a powerful dual campaign. The HCP campaign used a glider to represent the precision of Empliciti in enhancing immune response. The patient campaign featured selfies photo and selfie videos from real patients, focusing on empowerment. The tagline “Picture Yourself Powering Up Your Immune System” highlighted Empliciti’s role as a monoclonal antibody, boosting immune strength. The campaign resonated deeply with the multiple myeloma community for its uplifting message.

ELOPT21415_Caregiver_Brochure_GStoAD_C00_16_nomarkups_Page_10.jpg

ELOPT21415_Caregiver_Brochure_GStoAD_C00_16_nomarkups_Page_09.jpg

ELOPT21415_Caregiver_Brochure_GStoAD_C00_16_nomarkups_Page_08.jpg

ELOPT21415_Caregiver_Brochure_GStoAD_C00_16_nomarkups_Page_07.jpg

ELOPT21415_Caregiver_Brochure_GStoAD_C00_16_nomarkups_Page_06.jpg

ELOPT21415_Caregiver_Brochure_GStoAD_C00_16_nomarkups_Page_05.jpg

ELOPT21415_Caregiver_Brochure_GStoAD_C00_16_nomarkups_Page_04.jpg

ELOPT21415_Caregiver_Brochure_GStoAD_C00_16_nomarkups_Page_03.jpg

ELOPT21415_Caregiver_Brochure_GStoAD_C00_16_nomarkups_Page_02.jpg

ELOPT21415_Caregiver_Brochure_GStoAD_C00_16_nomarkups_Page_01.jpg

prev / next

1 2 3 4 5 6 7 8 9 10 11 12

· · · · · · · · · · · ·